NCT02292186
- Conditions
- Alzheimer Disease, Brain Diseases, Cardiomyopathies, +11 more
- Locations
-
- Clinical Trial Site Boston, Massachusetts, United States
- Clinical Trial Site New York, United States
- Clinical Trial Site Cleveland, Ohio, United States
- Clinical Trial Site Calgary, Alberta, Canada